Triplixam

Triplixam belongs to Fondation Internationale de Recherche Servier through Les Laboratoires Servier SAS → Servier SAS. Triplixam is owned by Fondation Internationale de Recherche Servier, headquartered in France. No. The ultimate owner of Triplixam, Fondation Internationale de Recherche Servier, is headquartered in France, not in the United States.

A global pharmaceutical company governed by a non-profit foundation, specializing in cardiology, oncology, and metabolic diseases.

Laboratórios Servier do Brasil Ltda.